Work

Tumor mutational burden (TMB) and response rates to immune checkpoint inhibitors (ICIs) targeting PD-1, CTLA-4, and combination.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.2578

Authors: Arsen Osipov, Aleksandra Popovic, Alexander Hopkins, Garrett M. Frampton, Lee A. Albacker, Nilofer Saba Azad, Daniel A. Laheru, Lei Zheng, Elizabeth M. Jaffee, Mark Yarchoan

Institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Foundation Medicine (United States), Johns Hopkins Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947394248

Cites:

Cited by: 4

Related to: 10